Futura Medical plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FAMDF research report →
About the company
Futura Medical plc is a pharmaceutical company that formulates and brings to market healthcare solutions and medicines for the consumer sector, primarily concentrating on sexual well-being and managing discomfort. Their flagship product, MED3000, is a topical gel specifically developed to address erectile dysfunction. The company's pipeline also encompasses a range of pain relief treatments, featuring TPR100, a topical diclofenac gel; CBD100, a topical cannabidiol preparation; and TIB200, a topical ibuprofen gel.
- CEO
- Alex Duggan
- IPO
- 2012
- Employees
- 14
- HQ
- Guildford, GB
Price Chart
- Market Cap
- $2.38M
- P/E
- -0.21
- P/S
- 1.12
- P/B
- 1.15
- EV/EBITDA
- 0.27
- Div Yield
- 0.00%
- Gross Margin
- 73.08%
- Op Margin
- -333.48%
- Net Margin
- -534.62%
- ROE
- -310.00%
- ROIC
- -180.43%
- Revenue
- $1.70M · -87.82%
- Net Income
- $-9,069,227 · -801.40%
- EPS
- $-0.03 · -746.51%
- Op Income
- $-8,964,613
- FCF YoY
- -317.52%
- 52W High
- $0.20
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.02
- Avg Volume
- 24.36K
Get TickerSpark's AI analysis on FAMDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FAMDF coverage
Recent articles, reports, and earnings notes.
No research on FAMDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FAMDF report →Similar companies
Peers in the same neighborhood.